The U.S. ultrasound probe disinfection market size was estimated at USD 202.04 million in 2024 and is projected to reach USD 414.94 million by 2033, growing at a CAGR of 8.38% from 2025 to 2033. The demand for ultrasound probe disinfection in the U.S. is on the rise, driven by the growing prevalence of chronic conditions such as heart disease and cancer, increasing reliance on medical imaging, a surge in product approvals, and ongoing technological advancements in probe disinfection methods.
The rising burden of chronic disorders is a significant driver for the market. The growing prevalence of cardiovascular diseases is fueling the demand for echocardiograms-ultrasound procedures of the heart that use phased array probes. According to data released by MedStar Health in January 2024, over 7 million echocardiograms are conducted annually in the U.S., underscoring the increasing dependence on cardiac ultrasound for diagnostic purposes. This substantial volume of procedures necessitates regular and thorough disinfection of ultrasound probes to prevent cross-contamination and safeguard patient health. As the use of phased array probes continues to grow in cardiac procedures, stringent disinfection protocols become even more critical. Therefore, the expanding adoption of cardiac ultrasound is expected to drive the growth of the ultrasound probe disinfection market.
Furthermore, the growing burden of health conditions like rectal cancer, prostate cancer, infertility, and heart disease is expected to significantly increase the demand for high-level disinfection solutions that can disinfect semi critical probes in the coming years. As semi-critical probes come into direct contact with mucous membranes (such as the vagina, rectum, and pharynx), they require high-level disinfection to ensure patient safety and prevent the transmission of infections.
This product will be delivered within 1-3 business days.
The rising burden of chronic disorders is a significant driver for the market. The growing prevalence of cardiovascular diseases is fueling the demand for echocardiograms-ultrasound procedures of the heart that use phased array probes. According to data released by MedStar Health in January 2024, over 7 million echocardiograms are conducted annually in the U.S., underscoring the increasing dependence on cardiac ultrasound for diagnostic purposes. This substantial volume of procedures necessitates regular and thorough disinfection of ultrasound probes to prevent cross-contamination and safeguard patient health. As the use of phased array probes continues to grow in cardiac procedures, stringent disinfection protocols become even more critical. Therefore, the expanding adoption of cardiac ultrasound is expected to drive the growth of the ultrasound probe disinfection market.
Furthermore, the growing burden of health conditions like rectal cancer, prostate cancer, infertility, and heart disease is expected to significantly increase the demand for high-level disinfection solutions that can disinfect semi critical probes in the coming years. As semi-critical probes come into direct contact with mucous membranes (such as the vagina, rectum, and pharynx), they require high-level disinfection to ensure patient safety and prevent the transmission of infections.
U.S. Ultrasound Probe Disinfection Market Report Segmentation
This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the U.S. ultrasound probe disinfection market report based on product, method, and end-use:Product Outlook (Revenue, USD Million, 2021 - 2033)
- Instruments
- Automated Reprocessors
- UV-C Disinfectors
- Manual Reprocessors/Soaking Stations
- Ultrasound Probe Storage Cabinets
- Consumables
- Consumables, By Formulations
- Disinfectant Liquids
- Disinfectant Wipes
- Disinfectant Sprays
- Consumables, By Detergent
- Enzymatic Detergents
- Non-enzymatic Detergents
- Service
Method Outlook (Revenue, USD Million, 2021 - 2033)
- High-Level Disinfection
- Intermediate Level Disinfection/Low-Level Disinfection
End-use Outlook (Revenue, USD Million, 2021 - 2033)
- Hospitals and Clinics
- Diagnostic Imaging Centers
- Others
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. U.S. Ultrasound Probe Disinfection Market Variables, Trends & Scope
Chapter 4. U.S. Ultrasound Probe Disinfection Market: Product Estimates & Trend Analysis
Chapter 5. U.S. Ultrasound Probe Disinfection Market: Method Estimates & Trend Analysis
Chapter 6. U.S. Ultrasound Probe Disinfection Devices: End Use Estimates & Trend Analysis
Chapter 7. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
- ASP (Fortive)
- Nanosonics
- CIVCO Medical Solutions
- Tristel Plc
- Ecolab Inc.
- Germitec
- CS Medical LLC
- Steelco S.p.A
- STERIS
- EDM Medical Solutions
- GE HealthCare
- UV Smart
- The Clorox Company
- Ruhof Corporation
